Short Communication

Oncogene (2008) 27, 2488–2493; doi:10.1038/sj.onc.1210890; published online 29 October 2007

Human APC sequesters bold beta-catenin even in the absence of GSK-3bold beta in a Drosophila model

P R Rao1, K Makhijani1 and L S Shashidhara1

1Centre for Cellular and Molecular Biology, Hyderabad, India

Correspondence: Dr PR Rao, Drosophila Genetics, Centre for Cellular and Molecular Biology, Uppal Road, Tarnaka, Hyderabad, Andhra Pradesh 500 007, India. E-mail: prashanth21676@gmail.com

Received 16 May 2007; Revised 4 September 2007; Accepted 1 October 2007; Published online 29 October 2007.

Top

Abstract

There have been conflicting reports on the requirement of GSK-3beta-mediated phosphorylation of the tumor suppressor adenomatous polyposis coli (APC) vis-à-vis its ability to bind and degrade beta-catenin. Using a unique combination of loss of function for Shaggy/GSK-3beta and a gain of function for human APC in Drosophila, we show that misexpressed human APC (hAPC) can still sequester Armadillo/beta-catenin. In addition, human APC could suppress gain of Wnt/Wingless phenotypes associated with loss of Shaggy/GSK-3beta activity, suggesting that sequestered Armadillo/beta-catenin is non-functional. Based on these studies, we propose that binding per se of beta-catenin by APC does not require phosphorylation by GSK-3beta.

Keywords:

colon cancer, adenomatous polyposis coli, Shaggy/GSK-3beta, Armadillo, Wnt, Wingless

Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

NEWS AND VIEWS

β-catenin ? one player, two games

Nature Genetics News and Views (01 May 1997)

Extra navigation

.

naturejobs

natureproducts


ADVERTISEMENT